Skip to main content

Table 2 Radiotherapy delivery

From: A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma

Dose level

N

Radiation therapy dose (Gy)

Dose delay due to AE

Level 1

3

62

62a

64

1 (3 days)

Level 2

6

64

60

62

0

 

64

62

60

Level 3

6

60

64

62

1 (7 days)

 

64

60b

62

  1. aGrade 3 esophagitis
  2. bGrade 3 pneumonitis